Comparison of real-world hypoglycemia rates among Patients Initiating Treatment with Saxagliptin or Glipizide
This study compared hypoglycemia rates in patients with type 2 diabetes on metformin who augmented treatment with saxagliptin or glipizide 5-20 mg/day.
Source: Value in Health - Category: Global & Universal Authors: S. Johnston, K. Bell, E. Thomson, G. Lenhart, J. Sheehan Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Glipizide | Health | International Medicine & Public Health | Metformin | Study